In a recent study was demonstrated that down-regulation of Ulk1 suppresses NSCLC cell growth and sensitizes NSCLC cells to cisplatin by modulating both apoptosis and autophagy pathways (Tang et al., 2017). The gene discussed is ULK1; the disease is non-small cell lung carcinoma.